Cargando…

Protein Kinases and Neurodegenerative Diseases

Detalles Bibliográficos
Autores principales:	Kawahata, Ichiro, Fukunaga, Kohji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058590/ https://www.ncbi.nlm.nih.gov/pubmed/36982647 http://dx.doi.org/10.3390/ijms24065574

Ejemplares similares

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
por: Kawahata, Ichiro, et al.
Publicado: (2022)

Degradation of Tyrosine Hydroxylase by the Ubiquitin-Proteasome System in the Pathogenesis of Parkinson’s Disease and Dopa-Responsive Dystonia
por: Kawahata, Ichiro, et al.
Publicado: (2020)

Plasma sphingolipid abnormalities in neurodegenerative diseases
por: Oizumi, Hideki, et al.
Publicado: (2022)

Fatty Acid Binding Protein 5 Mediates Cell Death by Psychosine Exposure through Mitochondrial Macropores Formation in Oligodendrocytes
por: Cheng, An, et al.
Publicado: (2020)

Impact of Fatty Acid-Binding Proteins in α-Synuclein-Induced Mitochondrial Injury in Synucleinopathy
por: Cheng, An, et al.
Publicado: (2021)

A novel fatty acid-binding protein 5 and 7 inhibitor ameliorates oligodendrocyte injury in multiple sclerosis mouse models
por: Cheng, An, et al.
Publicado: (2021)

Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP(+)-Induced Mitochondrial Dysfunction in Cultured Dopaminergic Neurons
por: Kawahata, Ichiro, et al.
Publicado: (2019)

Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson’s Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique
por: Kawahata, Ichiro, et al.
Publicado: (2023)

Epidermal Fatty Acid-Binding Protein 5 (FABP5) Involvement in Alpha-Synuclein-Induced Mitochondrial Injury under Oxidative Stress
por: Wang, Yifei, et al.
Publicado: (2021)

The Role of CaMKII and ERK Signaling in Addiction
por: Jia, Wenbin, et al.
Publicado: (2021)

Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets
por: Guo, Qingyun, et al.
Publicado: (2022)

T-Type Ca(2+) Enhancer SAK3 Activates CaMKII and Proteasome Activities in Lewy Body Dementia Mice Model
por: Xu, Jing, et al.
Publicado: (2021)

Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons
por: Guo, Qingyun, et al.
Publicado: (2022)

Protein Misfolding and Neurodegenerative Diseases
por: Cardinale, Alessio, et al.
Publicado: (2014)

Fatty Acid-Binding Proteins Aggravate Cerebral Ischemia-Reperfusion Injury in Mice
por: Guo, Qingyun, et al.
Publicado: (2021)

Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors in Mice by an FABP3 Inhibitor
por: Jia, Wenbin, et al.
Publicado: (2023)

SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App(NL-G-F/NL-G-F) Knock-in Mice by Increasing Proteasome Activity through CaMKII/Rpt6 Signaling
por: Izumi, Hisanao, et al.
Publicado: (2020)

Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice
por: Yuan, Dian, et al.
Publicado: (2021)

Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain
por: Yabuki, Yasushi, et al.
Publicado: (2020)

Advances in Neurodegenerative Diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2023)

Lipids in Neurodegenerative Diseases
por: Chiurchiù, Valerio
Publicado: (2023)

Mitochondria in neurodegenerative diseases
por: Lin, Fang, et al.
Publicado: (2019)

Biomarkers in Neurodegenerative Diseases
por: Ghosh, Arnab
Publicado: (2022)

Advances in Neurodegenerative Diseases
por: Siokas, Vasileios, et al.
Publicado: (2022)

α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss
por: Guo, Qingyun, et al.
Publicado: (2023)

Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases
por: Zhang, Hui-Liang, et al.
Publicado: (2022)

Neurodegenerative Diseases: Mechanisms and Therapies
por: Smith, Mark A., et al.
Publicado: (2006)

Pain Assessment in Neurodegenerative Diseases
por: de Tommaso, Marina, et al.
Publicado: (2016)

Multitarget Therapeutics for Neurodegenerative Diseases
por: Gabr, Moustafa T., et al.
Publicado: (2020)

Neuroplasticity in the Pathology of Neurodegenerative Diseases
por: Dorszewska, Jolanta, et al.
Publicado: (2020)

Biochemical Biomarkers and Neurodegenerative Diseases
por: Ciaccio, Marcello
Publicado: (2021)

Oxidative Stress in Neurodegenerative Diseases
por: Domanskyi, Andrii, et al.
Publicado: (2022)

An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3
por: Fukui, Naoya, et al.
Publicado: (2021)

Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease
por: Benn, Caroline L., et al.
Publicado: (2020)

Marijuana's potential in neurodegenerative diseases: an editorial
por: Arachchige, Arosh S. Perera Molligoda
Publicado: (2023)

Prevention, Intervention and Care of Neurodegenerative Diseases
por: Bakirtzis, Christos, et al.
Publicado: (2023)

Neurodegenerative Diseases: Molecular Mechanisms and Therapies
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Traditional Medicine for Treatment of Neurodegenerative Diseases
por: Wu, Chun Fu, et al.
Publicado: (2014)

Oxidative Stress in Neurodegenerative Diseases and Ageing
por: Pereira, Marcos D., et al.
Publicado: (2012)

Imaging Neurodegenerative Diseases: Mechanisms and Interventions
por: Bai, Lijun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_s9ufkqh6iijnqcsjg80ugj3v9j